loader
Please Wait
Applying Filters...
menu
    • menu

    Quality Alerts: FDA issues Close Out Letter to Interquim S.A. - Interquim Sa

    MenuInterquim Sa

    Uploaded: 2022
    News
    Ferrer has announced completion 220 patients for PROSPER study

    21 Oct 2025

    // PRESS RELEASE

    Prilenia & Ferrer today announced Ph3 Data on Pridopidine

    05 Sep 2025

    // PRESS RELEASE

    Prilenia & Ferrer Provide Update on EU Reg. process Pridopidine

    25 Jul 2025

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Interquim

    Contact Supplier

    Website

    DCAT Week

    Lotte New York Palace

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.pharmacompass.com/video-pharmareel/interquim-sa/40-years-of-expertise
    Xls

    CATEGORY PAGE
    Menu

    Interquim Sa

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PI70364
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.